Literature DB >> 21764282

Chinese red yeast rice attenuates the development of angiotensin II-induced abdominal aortic aneurysm and atherosclerosis.

Xiaojie Xie1, Yifan Wang, Songzhao Zhang, Guidi Zhang, Yinchuan Xu, Honghao Bi, Alan Daugherty, Jian-an Wang.   

Abstract

OBJECTIVE: Abdominal aortic aneurysm (AAA) is a chronic vascular disease characterized by medial degradation and inflammation. No medical approaches have been validated for treating AAA, and therapeutic options are limited to regular surveillance leading to surgical intervention. This study aimed to investigate whether administration of Chinese red yeast rice (Monascus purpureus; RYR) suppressed angiotensin II (AngII)-induced AAA and atherosclerosis. METHODS AND
RESULTS: Apolipoprotein E-deficient male mice fed a normal diet were administered either RYR extract (200 mg/kg/day) or vehicle by gavage for 1 week before initiating AngII infusion (1000 ng/kg/min) via subcutaneous osmotic pumps for 28 days. Red yeast rice extract administration significantly suppressed AngII-induced expansion of suprarenal diameter and area (P<.05). Furthermore, RYR extract significantly reduced atherosclerotic lesion areas in both the intima of aortic arches and cross sections of aortic roots (P<.05). These effects were associated with reductions of serum total cholesterol, intercellular adhesion molecule 1, vascular cell adhesion molecule 1, matrix metalloproteinase (MMP) 2 and increases of serum macrophage migration inhibitory factor, but no changes in serum interleukin (IL) 1α, IL-6, monocyte chemoattractant protein 1, MMP-9 and expression of MMP-2 and MMP-9 in aortic walls.
CONCLUSIONS: This study demonstrated that RYR extract administration suppressed AngII-induced AAA and atherosclerosis associated with regulating inflammation responses independent of lipid-lowering effects. Red yeast rice may have preventive potential for patients with AAA.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21764282     DOI: 10.1016/j.jnutbio.2011.02.011

Source DB:  PubMed          Journal:  J Nutr Biochem        ISSN: 0955-2863            Impact factor:   6.048


  10 in total

Review 1.  Cholesterol-Lowering Nutraceuticals Affecting Vascular Function and Cardiovascular Disease Risk.

Authors:  Vanessa Bianconi; Massimo Raffaele Mannarino; Amirhossein Sahebkar; Teresa Cosentino; Matteo Pirro
Journal:  Curr Cardiol Rep       Date:  2018-05-25       Impact factor: 2.931

Review 2.  Functional food red yeast rice (RYR) for metabolic syndrome amelioration: a review on pros and cons.

Authors:  Seema Patel
Journal:  World J Microbiol Biotechnol       Date:  2016-04-02       Impact factor: 3.312

3.  Ginkgo biloba extracts prevent aortic rupture in angiotensin II-infused hypercholesterolemic mice.

Authors:  Xiao-Fang Huang; Song-Zhao Zhang; Ya-Yu You; Na Zhang; Hong Lu; Alan Daugherty; Xiao-Jie Xie
Journal:  Acta Pharmacol Sin       Date:  2018-05-18       Impact factor: 6.150

Review 4.  Monascus secondary metabolites: production and biological activity.

Authors:  Petra Patakova
Journal:  J Ind Microbiol Biotechnol       Date:  2012-11-20       Impact factor: 3.346

5.  Dietary Silicon Deficiency Does Not Exacerbate Diet-Induced Fatty Lesions in Female ApoE Knockout Mice.

Authors:  Ravin Jugdaohsingh; Katharina Kessler; Barbara Messner; Martin Stoiber; Liliana D Pedro; Heinrich Schima; Günther Laufer; Jonathan J Powell; David Bernhard
Journal:  J Nutr       Date:  2015-05-13       Impact factor: 4.798

Review 6.  Anti-inflammatory activity of traditional Chinese medicinal herbs.

Authors:  Min-Hsiung Pan; Yi-Shiou Chiou; Mei-Ling Tsai; Chi-Tang Ho
Journal:  J Tradit Complement Med       Date:  2011-10

7.  Chinese Herbal Medicine as a Potential Treatment of Abdominal Aortic Aneurysm.

Authors:  Sai Wang Seto; Dennis Chang; Hosen Kiat; Ning Wang; Alan Bensoussan
Journal:  Front Cardiovasc Med       Date:  2018-04-20

Review 8.  Traditional Chinese Medicine Protects against Cytokine Production as the Potential Immunosuppressive Agents in Atherosclerosis.

Authors:  Yan Ren; Wei Qiao; Dongliang Fu; Zhiwei Han; Wei Liu; Weijie Ye; Zunjing Liu
Journal:  J Immunol Res       Date:  2017-09-06       Impact factor: 4.818

9.  Ezetimibe Attenuates Atherosclerosis Associated with Lipid Reduction and Inflammation Inhibition.

Authors:  Chunmiao Tie; Kanglu Gao; Na Zhang; Songzhao Zhang; Jiali Shen; Xiaojie Xie; Jian-An Wang
Journal:  PLoS One       Date:  2015-11-10       Impact factor: 3.240

10.  Novel EGFR inhibitors attenuate cardiac hypertrophy induced by angiotensin II.

Authors:  Kesong Peng; Xinqiao Tian; Yuanyuan Qian; Melissa Skibba; Chunpeng Zou; Zhiguo Liu; Jingying Wang; Zheng Xu; Xiaokun Li; Guang Liang
Journal:  J Cell Mol Med       Date:  2016-01-14       Impact factor: 5.310

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.